| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |